The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Diagnosis and Management of Pituitary Carcinomas
Abstract
Pituitary carcinomas are rare, making up some 0.2% of all pituitary tumors, but represent a particular challenge to clinical practice. The diagnosis of a pituitary carcinoma requires evidence of metastatic disease, either outside the central nervous system (CNS) or as separate noncontiguous foci within the CNS. They may present as typical pituitary adenomas, which reveal their malignant character only as time progresses, or as peculiarly aggressive tumors ab initio. Recent changes in histopathological classification have clarified many of the features of such tumors, including immunohistochemical staining for Ki-67 and p53, but to date none has been found to be pathognomonic. The majority of carcinomas are secretory, usually arising from corticotroph tumors or prolactinomas, but all histological types and secretory patterns are represented. Treatment is by surgery, transsphenoidal wherever possible, and conventional and stereotactic radiotherapy, but ultimately, a plethora of therapies may be required, including various attempts at medical therapy. Chemotherapy in some instances probably prolongs survival, but, in general, their progress from the diagnosis of carcinomatous changes is progressive and inexorable. However, we do not believe there will be any real prospect of long-term survival until the development and use of therapies targeted at specific molecular abnormalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gerdes, J., Schwab, U., Lemke, H., & Stein, H. (1983) · International Journal of Cancer · doi:10.1002/ijc.2910310104 · Cited by 2,788
Bunge, R. G., Keettel, W. C., & Sherman, J. K. (1954) · Fertility and Sterility · doi:10.1016/s0015-0282(16)31802-7 · Cited by 1,176
Database of p53 gene somatic mutations in human tumors and cell lines.
Hollstein, M. C., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sørlie, T., Hovig, E. J., Smith‐Sørensen, B., Montesano, R., & Harris, C. C. (1994) · Europe PMC (PubMed Central) · Cited by 858
Bruns, C., Lewis, I., Briner, U., Meno-Tetang, G., & Weckbecker, G. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460707 · Cited by 692
The diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674
Self-citationHall, W. A., Luciano, M. G., Doppman, J. L., Patronas, N. J., & Oldfield, E. H. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-10-199405150-00001 · Cited by 627
Microadenomas of the Pituitary and Abnormal Sellar Tomograms in an Unselected Autopsy Series
Burrow, G. N., Wortzman, G., Rewcastle, N. B., Holgate, R. C., & Kovacs, K. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101153040306 · Cited by 486
Thapar, K., Kovacs, K., Scheithauer, B. W., Stefaneanu, L., Horvath, E., Peter J., P., Murray, D., & Laws, E. R. (1996) · Neurosurgery · doi:10.1097/00006123-199601000-00024 · Cited by 462
The pathogenesis of pituitary tumours
Asa, S. L., & Ezzat, S. (2002) · Nature Reviews Cancer · doi:10.1038/nrc926 · Cited by 435
Tumors Metastatic to the Pituitary Gland: Case Report and Literature Review
Komninos, J., Vlassopoulou, V., Protopapa, D., Korfias, S. I., Kontogeorgos, G., Sakas, D. E., & Thalassinos, N. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030395 · Cited by 432
Self-citationRisk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.
Brada, M., Ford, D., Ashley, S., Bliss, J. M., Crowley, S., Mason, M., Rajan, B., & Traish, D. (1992) · BMJ · doi:10.1136/bmj.304.6838.1343 · Cited by 413
Meij, B. P., Lopes, M.-B. S., Ellegala, D. B., Alden, T. D., & Laws, E. R. (2002) · Journal of Neurosurgery · doi:10.3171/jns.2002.96.2.0195 · Cited by 327
Thapar, K., Scheithauer, B. W., Kovacs, K., Pernicone, P. J., & Laws, E. R. (1996) · Neurosurgery · doi:10.1097/00006123-199604000-00027 · Cited by 321
Gerdes, J., Becker, M. H. G., Key, G., Cattoretti, G., Sanders, H. W., Smith, A. G., Crocker, J., Darnton, S. J., Gray, M. R., & Crocker, J. (1992) · The Journal of Pathology · doi:10.1002/path.1711680114 · Cited by 320
Angiogenesis in Endocrine Tumors
Turner, H. E., Harris, A. L., Melmed, S., & Wass, J. A. H. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0008 · Cited by 275
Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy
Krenning, E. P., de Jong, M., Kooij, P. P. M., Breeman, W. A. P., Bakker, W. H., de Herder, W. W., van Eijck, C. H. J., Kwekkeboom, D. J., Jamar, F., Pauwels, S., et al. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_2.s23 · Cited by 234
H-ras mutations in human pituitary carcinoma metastases
Pei, L. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.4.842 · Cited by 216
Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours
Kaltsas, G., Rockall, A., Papadogias, D., Reznek, R., & Grossman, A. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510015 · Cited by 206
Self-citationLidhar, K. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.10.3823 · Cited by 196
Chemotherapy targeted to cancers through tumoral hormone receptors
Schally, A. V., & Nagy, A. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.07.002 · Cited by 184
Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumors.
Örlefors, H., Sundín, A., Ahlström, H. K., Bjurling, P., Bergström, M., Lilja, A., Långström, B., Öberg, K., & Eriksson, B. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2534 · Cited by 147
Korbonits, M., Chahal, H., Kaltsas, G., Jordan, S., URMANOVA, Y. M., Khalimova, Z., Harris, P. E., Farrell, W. E., Claret, F.-X., & Grossman, A. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2635 · Cited by 119
Self-citationThe Role of PET in Localization of Neuroendocrine and Adrenocortical Tumors
Eriksson, B. K., Bergström, M., Sundin, A., Juhlin, C., Örlefors, H., Öberg, K., & Långström, B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04422.x · Cited by 109
Ayuk, J., Stewart, S. E., Stewart, P. M., & Sheppard, M. C. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011913 · Cited by 95
Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues
Wiseman, G. A., & Kvols, L. K. (1995) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(95)80016-6 · Cited by 94
Corticotroph carcinoma of the pituitary: a clinicopathological study
Gaffey, T. A., Scheithauer, B. W., Lloyd, R. V., Burger, P. C., Robbins, P., Fereidooni, F., Horváth, É., Kovács, K., Kuroki, T., Young, W. F., et al. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.96.2.0352 · Cited by 86
Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours
Kaltsas, G., Kola, B., Borboli, N., Morris, D. G., Gueorguiev, M., Swords, F. M., Czirják, S., Kirschner, L. S., Stratakis, C. A., Korbonits, M., et al. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01643.x · Cited by 81
Self-citationKaltsas, G., Mukherjee, J. J., & Grossman, A. B. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s47 · Cited by 70
Self-citationApoptosis in Nontumorous and Neoplastic Human Pituitaries
Kulig, E., Jin, L. G., Qian, X., Horváth, É., Kovács, K., Ştefăneanu, L., Scheithauer, B. W., & Lloyd, R. V. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65323-0 · Cited by 68
Öngürü, Ö., Scheithauer, B. W., Kovács, K., et al. (2004) · Modern Pathology · doi:10.1038/modpathol.3800118 · Cited by 66
Are Markers of Proliferation Valuable in the Histological Assessment of Pituitary Tumours?
Turner, H. E., & Wass, J. A. H. (1999) · Pituitary · doi:10.1023/a:1009979128608 · Cited by 62
Stereotactic Radiosurgery XVI: A Treatment for Previously Irradiated Pituitary Adenomas
Swords, F. M., Allan, C. A., Plowman, P. N., Sibtain, A., Evanson, J., Chew, S. L., Grossman, A. B., BESSER, G. M., & Monson, J. P. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020356 · Cited by 61
Self-citationc-myc, c-fos, and c-myb gene expression in human pituitary adenomas
Woloschak, M., Roberts, J. L., & Post, K. D. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.1.8027238 · Cited by 51
Corticotroph Pituitary Carcinoma: Case Report and Literature Review
Holthouse, D., Robbins, P., Kahler, R. J., Knuckey, N. W., & Pullan, P. T. (2001) · Endocrine Pathology · doi:10.1385/ep:12:3:329 · Cited by 51
Pathology of MEN‐1: morphology, clinicopathologic correlations and tumour development
Komminoth, Heitz, & Klöppel (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00274.x · Cited by 49
Clonality of Pituitary Tumours: More Complicated than Initially Envisaged?
Clayton, R. N., & Farrell, W. E. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00402.x · Cited by 48
Kaltsas, G., Mukherjee, J. J., Isidori, A. M., Kola, B., Plowman, P. N., Monson, J. P., Grossman, A. B., & BESSER, G. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01589.x · Cited by 47
Self-citationGonadotropic Pituitary Carcinoma
Beauchesne, P. D., Trouillas, J., Barral, F. G., & Brunon, J. (1995) · Neurosurgery · doi:10.1097/00006123-199510000-00027 · Cited by 44
Genetic Basis of Pituitary Adenoma Invasiveness: A Review
Suhardja, A., Kovács, K., & Rutka, J. T. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010655419332 · Cited by 43
ACTH-producing carcinoma of the pituitary with haematogenic metastases
Garrao, A., Sobrinho, L. G., Pedro-Oliveira, Bugalho, M. J., Boavida, J. M., Raposo, J. F., Loureiro, M., Limbert, E., Costa, I., & Antunes, J. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1370176 · Cited by 38
Interferon-α-2a Is a Potent Inhibitor of Hormone Secretion by Cultured Human Pituitary Adenomas
Hofland, L. J., de Herder, W. W., Waaijers, M., Zuijderwijk, J. M., Uitterlinden, P., van Koetsveld, P. M., & Lamberts, S. W. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.6005 · Cited by 31
Analysis of Cox-2 and Thromboxane Synthase Expression in Pituitary Adenomas and Carcinomas
Öngürü, Ö., Scheithauer, B. W., Kovács, K., Vidal, S., Jin, L., Zhang, S., Ruebel, K. H., & Lloyd, R. V. (2004) · Endocrine Pathology · doi:10.1385/ep:15:1:17 · Cited by 29
Jin, L. G., Zhang, S., Bayliss, J. M., Scheithauer, B. W., Qian, X., Kobayashi, I., Stridsberg, M., & Lloyd, R. V. (2003) · Endocrine Pathology · doi:10.1385/ep:14:1:37 · Cited by 21
ACTH-Producing Pituitary Cancer: Experience at the King Faisal Specialist Hospital & Research Centre
Ahmed, M., Kanaan, I., Alarifi, A., Ba-Essa, E., Saleem, M., Tulbah, A. M., McArthur, P. D., & Hessler, R. B. (2000) · Pituitary · doi:10.1023/a:1009957824871 · Cited by 19
Cited by
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline
Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1692 · Cited by 1,844
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Advances in the Treatment of Prolactinomas
Gillam, M. P., Molitch, M. E., Lombardi, G., & Colao, A. (2006) · Endocrine Reviews · doi:10.1210/er.2005-9998 · Cited by 824
Metadata
- Authors
- Kaltsas, G. A., Nomikos, P., Kontogeorgos, G., Buchfelder, M., & Grossman, A. B.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-05
- Volume
- 90
- Issue
- 5
- Pages
- 3089-3099
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1998829259
- Cited by
- 325
- References
- 44
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.